LTFS
DTIL icon

Ladenburg Thalmann Financial Services’s Precision BioSciences DTIL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$35K Hold
83
– – ﹤0.01% 3776
2019
Q3 		$21K Hold
83
– – ﹤0.01% 4013
2019
Q2 		$33K Buy
+83
New +$33.4K ﹤0.01% 3744

Other funds holding DTIL

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
ACWM
Adams Chetwood Wealth Management Durham, North Carolina $176M AUM 8.48% 1-Year Est. Return

Ladenburg Thalmann Financial Services's DTIL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Precision BioSciences (DTIL) position steady in Q4 2019 at 83 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #3776.

Ladenburg Thalmann Financial Services first reported a position in DTIL in Q2 2019 and has held it in 3 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 83 shares of Precision BioSciences worth $35K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Precision BioSciences share count unchanged in Q4 2019.
  • Precision BioSciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3776 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Precision BioSciences in Q2 2019 and has held it in 3 quarters since.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.